Takayuki Katsuyama

Takayuki Katsuyama

Auto-generated profile, based on publicly available information

Takayuki Katsuyama

Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2016 in Modern Rheumatology
Verified
Journal Article
Closed access
TKTakayuki Katsuyama
Takayuki Katsuyama
KSKen-Ei Sada
Ken-Ei Sada
MYMinglu Yan
Minglu Yan
SZSonia Zeggar
Sonia Zeggar
SHSumie Hiramatsu
Sumie Hiramatsu
JWJun Wada
Jun Wada
Objectives: To determine prognostic factors of methotrexate-associated lymphoproliferative disorder (MTX-LPD) and evaluate the efficacy and safety of biological therapy in rheumatoid arthritis (RA) complicated with MTX-LPD. Methods: Thirty RA patients who developed MTX-LPD were investigated in this study. We compared the clinical and laboratory parameters of patients who achieved regression of LPD by MTX withdrawal with those who required chemotherapy and evaluated the clinical course of RA after LPD development. Results: Twenty-three patients (76.7%) achieved regression of LPD by MTX withdrawal. Chemotherapy-free patients had a tendency of shorter RA duration (13.1 vs. 22.0 years, p = 0.108) and higher doses of MTX at LPD diagnosis (8.0 vs. 5.3 mg/w, p = 0.067) than patients who required chemotherapy. A significantly higher positive rate of peripheral blood Epstein–Barr virus (EBV)-DNA was observed in the chemotherapy-free group (9/9 vs. 0/3, p = 0.0002). Of 15 patients that received biological agents after LPD development, 14 patients (93.3%) demonstrated an improved disease activity of RA and persistent remission of LPD, whereas only one patient experienced relapse of LPD during tocilizumab therapy. Conclusions: Peripheral blood EBV-DNA positivity is a potential prognostic marker of better outcome in MTX-LPD. Biological agents could be an option for the treatment of RA patients with MTX-LPD.

1 April 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YMYoshinori Y; Yoshinori Matsumoto
Yoshinori Y; Yoshinori Matsumoto
IDIoannis D. Dimitriou
Ioannis D. Dimitriou
JRJose La Rose
Jose La Rose
MLMelissa Lim
Melissa Lim
SCSusan Camilleri
Susan Camilleri
RRRobert Rottapel
Robert Rottapel
Dysregulation of Toll-like receptor (TLR) signaling contributes to the pathogenesis of autoimmune diseases. Here, we provide genetic evidence that tankyrase, a member of the poly(ADP-ribose) polymerase (PARP) family, negatively regulates TLR2 signaling. We show that mice lacking tankyrase in myeloid cells developed severe systemic inflammation with high serum inflammatory cytokine levels. We provide mechanistic evidence that tankyrase deficiency resulted in tyrosine phosphorylation and activation of TLR2 and show that phosphorylation of tyrosine 647 within the TIR domain by SRC and SYK kinases was critical for TLR2 stabilization and signaling. Last, we show that the elevated cytokine production and inflammation observed in mice lacking tankyrase in myeloid cells were dependent on the adaptor protein 3BP2, which is required for SRC and SYK activation. These data demonstrate that tankyrase provides a checkpoint on the TLR-mediated innate immune response.

1 November 2015 in Peptides
Verified
Journal Article
Open access
TKTakayuki Katsuyama
Takayuki Katsuyama
FOFumio Otsuka
Fumio Otsuka
TTTomohiro Terasaka
Tomohiro Terasaka
IKInagaki Kenichi
Inagaki Kenichi
MTMariko Takano-Narazaki
Mariko Takano-Narazaki
HMHirofumi Makino
Hirofumi Makino
BMP induces osteoblast differentiation, whereas a key proinflammatory cytokine, TNF-α, causes inflammatory bone damage shown in rheumatoid arthritis. FGF molecules are known to be involved in bone homeostasis. However, the effects of FGF-8 on osteoblast differentiation and the interaction between FGF-8, BMPs and TNF-α have yet to be clarified. Here we investigated the effects of FGF-8 in relation to TNF-α actions on BMP-2-induced osteoblast marker expression using myoblast cell line C2C12, osteoblast precursor cell line MC3T3-E1 and rat calvarial osteoblasts. It was revealed that FGF-8 inhibited BMP-2-induced expression of osteoblast differentiation markers, including Runx2, osteocalcin, alkaline phosphatase, type-1 collagen and osterix, in a concentration-dependent manner. The inhibitory effects of FGF-8 on BMP-induced osteoblast differentiation and Smad1/5/8 activation were enhanced in the presence of TNF-α action. FGF-8 also inhibited BMP-2-induced expression of Wnt5a, which activates a non-canonical Wnt signaling pathway. FGF-8 had no significant influence on the expression levels of TNF receptors, while FGF-8 suppressed the expression of inhibitory Smad6 and Smad7, suggesting a possible feedback activity through FGF to BMP receptor (BMPR) signaling. Of note, inhibition of ERK activity and FGF receptor (FGFR)-dependent protein kinase, but not JNK or NFκB pathway, suppressed the FGF-8 actions on BMP-induced osteoblast differentiation. FGF-8 was revealed to suppress BMP-induced osteoblast differentiation through the ERK pathway and the effects were enhanced by TNF-α. Given the finding that FGF-8 expression was increased in synovial tissues of rheumatoid arthritis, the functional interaction between FGFR and BMPR signaling may be involved in the development process of inflammatory bone damage.

20 May 2022 in Rheumatology
Verified
Journal Article
Closed access
PDF file
YKYu Katayama
Yu Katayama
TKTakayuki Katsuyama
Takayuki Katsuyama
KSKenta Shidahara
Kenta Shidahara
SNShoichi Nawachi
Shoichi Nawachi
YAYosuke Asano
Yosuke Asano
JWJun Wada
Jun Wada
Dear Editor, IgG4-related disease (IgG4-RD) is a chronic systemic disease characterized by the elevation of serum IgG4, infiltration of lymphocytes and IgG4-positive plasma cells, and fibrosis [ 1]. IgG4-RD affects any organs such as salivary glands, orbits, pancreas, kidneys, aorta, retroperitoneum and mimics malignancy, infection, and other autoimmune diseases including SLE. SLE is also a chronic inflammatory disease that presents variable symptoms, and IgG4-RD and SLE rarely coexist. The first-line treatment of IgG4-RD is glucocorticoids (GCs). Although IgG4-RD usually shows a good response to GCs, it often relapses. When GC treatment fails, there is no evidence on what immunosuppressive agents should be added next. We herein report a case of IgG4-RD complicated with SLE, successfully treated with belimumab for the relapse of IgG4-RD, not SLE, possibly leading to novel insights into the treatment of IgG4-RD. A 76-year-old man with fatigue and 4 kg weight loss was admitted to...

25 May 2023 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
YMYoshia Miyawaki
Yoshia Miyawaki
KSKen-Ei Sada
Ken-Ei Sada
KSKenta Shidahara
Kenta Shidahara
SNShoichi Nawachi
Shoichi Nawachi
YAYosuke Asano
Yosuke Asano
NKNoriaki Kurita
Noriaki Kurita
Objectives: There is a high prevalence of burnout among rheumatologists. Grit, which is defined as possessing perseverance and a passion to achieve long-term goals, is predictive of success in many professions; however, whether grit is associated with burnout remains unclear, especially among academic rheumatologists, who have multiple simultaneous responsibilities. Thus, the purpose of this study was to examine the associations between grit and self-reported burnout components—professional efficacy, exhaustion, and cynicism—in academic rheumatologists. Methods: This cross-sectional study involved 51 rheumatologists from 5 university hospitals. The exposure was grit, measured using mean scores for the 8-item Short Grit Scale (range, 1–5 [5 = extremely high grit]). The outcome measures were mean scores for 3 burnout domains (exhaustion, professional efficacy, and cynicism; range, 1–6; measured using the 16-item Maslach Burnout Inventory–General Survey). General linear models were fitted with covariates (age, sex, job title [assistant professor or higher vs lower], marital status, and having children). Results: Overall, 51 physicians (median age, 45 years; interquartile range, 36–57; 76% men) were included. Burnout positivity was found in 68.6% of participants (n = 35/51; 95% confidence interval [CI], 54.1, 80.9). Higher grit was associated with higher professional efficacy (per 1-point increase; 0.51 point; 95% CI, 0.18, 0.84) but not with exhaustion or cynicism. Being male and having children were associated with lower exhaustion (−0.69; 95% CI, −1.28, −0.10; p = 0.02; and −0.85; 95% CI, −1.46, −0.24; p = 0.006). Lower job title (fellow or part-time lecturer) was associated with higher cynicism (0.90; 95% CI, 0.04, 1.75; p = 0.04). Conclusions: Grit is associated with higher professional efficacy among academic rheumatologists. To prevent burnout among staff, supervisors who manage academic rheumatologists should assess their staff's individual grit.

1 January 2023 in Rheumatology Advances in Practice
Verified
Journal Article
Open access
PDF file
TNTakato Nakadoi
Takato Nakadoi
EKEri Katsuyama
Eri Katsuyama
KMKazuya Matsumoto
Kazuya Matsumoto
KSKenta Shidahara
Kenta Shidahara
KHKei Hirose
Kei Hirose
JWJun Wada
Jun Wada
Dear Editor, Sitosterolaemia is a primary dyslipidaemia involving the abnormal accumulation of sitosterol due to a loss-of-function mutation in the ABCG5 gene and causes early-onset severe arteriosclerosis [ 1]. Sitosterolaemia causes severe juvenile arteriosclerosis, subcutaneous xanthomas and Achilles tendonitis; however, certain cases are underdiagnosed, as they sometimes have normal lipid profiles for triglycerides and cholesterol. It is extremely rare for rheumatologists to encounter cases of sitosterolaemia, as it has a prevalence of 1 in ≈200 000 individuals [ 1]. We experienced a case of sitosterolaemia mimicking Takayasu arteritis. [18F]-2-fluoro-2-deoxy-D-glucose (FDG)-PET showed utility for making a clear differential diagnosis between sitosterolaemia and Takayasu arteritis.